rnai screening in drosophila cells identifies new modifiers of mutant huntingtin aggregationrnai筛查在果蝇细胞识别新的突变杭丁顿蛋白聚合修饰符.pdfVIP

RNAi Screening in Drosophila Cells Identifies New Modifiers of Mutant Huntingtin Aggregation 1 1 1 2 1 Joanna Doumanis , Koji Wada , Yoshihiro Kino , Adrian W. Moore , Nobuyuki Nukina * 1 Lab for Structural Neuropathology, RIKEN Brain Science Institute, Wako, Saitama, Japan, 2 Moore Research Unit, RIKEN Brain Science Institute, Wako, Saitama, Japan Abstract The fruitfly Drosophila melanogaster is well established as a model system in the study of human neurodegenerative diseases. Utilizing RNAi, we have carried out a high-throughput screen for modifiers of aggregate formation in Drosophila larval CNS-derived cells expressing mutant human Huntingtin exon 1 fused to EGFP with an expanded polyglutamine repeat (62Q). 7200 genes, encompassing around 50% of the Drosophila genome, were screened, resulting in the identification of 404 candidates that either suppress or enhance aggregation. These candidates were subjected to secondary screening in normal length (18Q)-expressing cells and pruned to remove dsRNAs with greater than 10 off-target effects (OTEs). De novo RNAi probes were designed and synthesized for the remaining 68 candidates. Following a tertiary round of screening, 21 high confidence candidates were analyzed in vivo for their ability to modify mutant Huntingtin-induced eye degeneration and brain aggregation. We have established useful models for the study of human HD using the fly, and through our RNAi screen, we have identified new modifiers of mutant human Huntingtin aggregation and aggregate formation in the brain. Newly identified modifiers including genes related to nuclear transport, nucleotide processes, and signaling, may be involved in polyglutamine aggregate formation and Huntington disease cascades. C